Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 500 mg, tablett med modifierad frisättning |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 1 g, dospåse med granulat med modifierad frisättning |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
Mesalazine 400 mg gastro-resistant oral tablet |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 400 mg, tablett med modifierad frisättning |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin250 mg, kapsel med modifierad frisättning |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 500 mg, dospåse med granulat med modifierad frisättning |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
Mesalazine 400 mg gastro-resistant oral tablet |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
Mesalazine 1.2 g gastro-resistant oral tablet |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 375 mg, kapsel med modifierad frisättning |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 400 mg, enterotablett |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 375 mg, depåkapsel |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 250 mg, depåkapsel |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
mesalazin 500 mg/dospåse, entero- och depågranulat |
Is a |
False |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|
Product containing only mesalazine in oral dose form (medicinal product form) |
Is a |
True |
Mesalazine-containing product in oral dose form |
Inferred relationship |
Some |
|